Sevens Elise SRL
Sevens Elise reported total assets of 53,817 € at the end of the 2026 financial year (annual accounts filed with the NBB on 17 Sep 2026).
The score of Sevens Elise shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2026
Change 2023 → 2026: Equity -88 % Total assets +36 %
Accounts of the company itself (not consolidated).
The full file covers 4 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Sevens Elise's annual accounts
Filed annual accounts
- Year ended 31 Mar 2026filed on 17 Sep 2026
- Year ended 31 Mar 2025filed on 14 Oct 2025
- Year ended 31 Mar 2024filed on 30 Oct 2024
- Year ended 31 Mar 2023filed on 27 Oct 2023
Sevens Elise's financial analysis
- Solvency6.0%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Sevens Elise
Sevens Elise's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0789.573.763
- VAT number
- BE0789573763
- Peppol
- Registered · 0208:0789573763 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 11 Aug 2022
- Registered office
- 9230 Wetteren
- Latest accounts
- 2026 · filed on 17 Sep 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Sevens Elise (SRL) has been based in Wetteren since 2022, active in: retail sale of pharmaceutical products. For 2026, it reports a net profit of 50,250 € and equity of 3,250 €; its revenue is not published. Its solvency stands at 6.0%, below the median of its sector (44.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Sevens Elise
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie Pharmiste Retail sale of pharmaceutical products Brussels · balance sheet 57,475 €
- Bephacon Retail sale of pharmaceutical products Beveren-Kruibeke-Zwijndrecht · balance sheet 52,631 €
- Astrid Fivez Retail sale of pharmaceutical products Destelbergen · balance sheet 52,168 €
- Apotheek A. Janssens Retail sale of pharmaceutical products Maasmechelen · balance sheet 55,793 €
- Pharmaes Retail sale of pharmaceutical products Anderlecht · balance sheet 57,673 €
- Eraphar Retail sale of pharmaceutical products Haaltert · balance sheet 50,132 €
- Sarah Spruyt Pharma & Care Retail sale of pharmaceutical products Mechelen · balance sheet 58,307 €
- Charlotte Slabbinck Retail sale of pharmaceutical products Oudenburg · balance sheet 72,938 €
Frequently asked questions about Sevens Elise
What is the revenue of Sevens Elise?
Sevens Elise files its accounts in a format where revenue is optional: it is not published for 2026.
What is the VAT number of Sevens Elise?
In Belgium, the VAT number is the company number prefixed with BE: BE0789573763 for Sevens Elise, if the company is VAT-registered. Its company number (CBE) is 0789.573.763.
Where is the registered office of Sevens Elise?
According to the CBE register, the registered office of Sevens Elise is in 9230 Wetteren.
What is the equity of Sevens Elise?
At the close of the 2026 financial year, the equity of Sevens Elise amounts to 3,250 €, a solvency of 6.0% of total assets.
Who manages Sevens Elise?
The register lists 1 active mandates at Sevens Elise. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Sevens Elise
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →